PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE1971.40-31.15 (-1.56 %)
PREV CLOSE ( ) 2002.55
OPEN PRICE ( ) 1990.00
BID PRICE (QTY) 1974.80 (5)
OFFER PRICE (QTY) 1976.85 (6)
VOLUME 1014
TODAY'S LOW / HIGH ( )1971.20 2048.45
52 WK LOW / HIGH ( )1625 2084
NSE1969.95-26.9 (-1.35 %)
PREV CLOSE( ) 1996.85
OPEN PRICE ( ) 2010.00
BID PRICE (QTY) 1969.30 (7)
OFFER PRICE (QTY) 1969.95 (5)
VOLUME 8232
TODAY'S LOW / HIGH( ) 1961.05 2010.00
52 WK LOW / HIGH ( )1642 2087
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-11 1950
Management Info
R A Shah - Chairman S Sridhar - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No.c-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 91 22 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerindia.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
30Oct Board Meeting For The Unaudited Finan
This is to inform you that a meeting of the Board of Directors of the Co..
11Oct Pfizer’s parent company mulling to spi
Pfizer’s parent company Pfizer Inc. is reviewing strategic alternatives..
11Oct Press Release / Media Release
Pfizer Limited has been informed by its parent company Pfizer Inc., USA,..
23Aug Pfizer receives patent for pneumonia v
Pfizer has been granted patent in India by the Indian Patent Office for..
31Jul Pfizer reports 29% fall in Q1 net profit
Pfizer has reported results for first quarter ended June 30, 2017. The c..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit1111.53367.8
Gross Profit 1747.7 5168.3
Operating Profit 1909.54502.9
Net Sales 5711.120419.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2302.30 (1.84%)
M.Cap (Rs. in Cr)38158.22
Natco Pharma (BSE)
 1000.15 (3.93%)
M.Cap (Rs. in Cr)17492.15
Wockhardt (BSE)
 753.70 (4.48%)
M.Cap (Rs. in Cr)8322.41
Piramal Enterprises (BSE)
 2749.00 (0.93%)
M.Cap (Rs. in Cr)47074.39
Ajanta Pharma (BSE)
 1439.10 (1.26%)
M.Cap (Rs. in Cr)12630.08
Shareholding Pattern
PROMOTERS 63.92%
NON-INSTITUTION 21.57%
MUTUAL FUNDS/UTI 8.34%
FI/BANKS/INSURANCE 3.32%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.